The Team of FluoSphera explains our technology and how it can reduce animal experimentation in a video interview!

JULY 26, 2022

The ultimate goal of alternatives to animal experimentation is not simply to provide models as relevant as animals, but much better! This is the best way to develop more potent and safer therapies for patients!

In this video (with also a teaser) made by LSCV, the team of FluoSphera explains how our technology is used as a powerful alternative to animal experimentation for drug discovery and for toxicity testing. 

LSCV featured the potential of FluoSphera’s technology as an alternative to animal experimentation in a press article!

JULY 25, 2022

LSCV featured the potential of FluoSphera’s technology as an alternative method to animal experimentation! Read the article here!

FluoSphera was selected to the MassChallenge U.S. early stage startup accelerator!

JULY 12, 2022

FluoSphera was selected to participate in the MassChallenge U.S. cohort 2022!

FluoSphera was selected to pitch at the SITEM Startup Club!

JUNE 29, 2022

FluoSphera was selected to present its technology at the SITEM Startup Club in Bern!

FluoSphera is an invited speaker at the NCCR Chemical Biology conference 2022!

JUNE 21, 2022

FluoSphera was invited to present its technology at the NCCR Chemical Biology Annual Conference!

FluoSphera just released a 3D animated movie on its technology!

JUNE 20, 2022

Finally released! The 3D animated movie made by Nanobot Medical Communications and presenting the technology of FluoSphera can be seen on the Home page of our website or directly on the YouTube channel of FluoSphera!

FluoSphera will be exhibiting at the BIO International Convention held in San Diego!

JUNE 13, 2022

FluoSphera will be exhibiting at the BIO International Convention held in San Diego with the support of Innosuisse, Presence Switzerland, Swisstech, and the Switzerland Global Enterprise!

Swisstech has made a video interview on FluoSphera!

JUNE 8, 2022

Swisstech has made a video interview for the participation of FluoSphera at the BIO International Convention held in San Diego!

FluoSphera is an invited speaker at the Micronarc Alpine Meeting!

MAY 30, 2022

FluoSphera was invited at the Micronarc Alpine Meeting through BioAlps to present its technology, with a specific focus on cell encapsulation by using microfluidics!

FluoSphera has a new logo!

MAY 19, 2022

FluoSphera has a new skin with our new logo designed by Nanobot Medical Communications!

FluoSphera will be at the Swiss Startup Days 2022!

MAY 19, 2022

FluoSphera will be present for partnering and fundraising at the Swiss Startup Days 2022!

FluoSphera will be at the Swiss Biotech Day!

MAY 2, 2022

FluoSphera will be at the Swiss Biotech Day, one of the most important Swiss biotech event of the year gathering the most important players of life sciences for partnering.

FluoSphera hired an R&D Technician!

MAY 2, 2022

FluoSphera hired an R&D technician to strengthen R&D on new biosystems!

Tribune de Genève wrote a press article on FluoSphera!

APRIL 6, 2022

The most popular daily journal of Geneva, Tribune de Genève, published an article featuring the technology of FluoSphera as a powerful tool for drug discovery and a promising alternative to animal experimentation!

FluoSphera will be exhibiting at BIO-Europe Spring 2022!

MARCH 28, 2022

FluoSphera will be virtually exhibiting at BIO-Europe Spring 2022, on of the biggest life sciences partnering events in Europe!

FluoSphera will be at the SACHS Life Sciences CEO Forum!

MARCH 1, 2022

SACHS Associates Life Sciences CEO Forum is an excellent event to meet with investors in the life sciences sector. FluoSphera will be presenting its technology as a unique opportunity to improve the quality of drugs for the patients, to reduce the costs of drug development failure, and to reduce animal experimentation.

FluoSphera was listed among Swiss companies providing alternatives to animal experimentation!

FEBRUARY 17, 2022

Venture Kick has made a video featuring Swiss companies providing alternatives to animal experimentation. Among them, FluoSphera!

FluoSphera won the second stage of Venture Kick!

FEBRUARY 9, 2022

 Second-round validation! FluoSphera gets an additional support of CHF 40’000 from Venture Kick for a total of CHF 50’000!

FluoSphera, speaker at the first event of the year at the Fongit!

JANUARY 24, 2022

FluoSphera was giving an overview (linked to the picture, starting at 18’40) of its mission and activities at the Fongit.

FluoSphera is now a company of the Fongit!

JANUARY 7, 2022

FluoSphera is now incubated at the Fongit, the Geneva Startup Incubator! Fongit’s incubation will be a tremendous help for the first years of FluoSphera. 

FluoSphera hires an R&D Scientist!

NOVEMBER 22, 2021

FluoSphera hires an R&D Scientist to implement R&D services and to develop our biosystem technology platforms. 

Live interview of FluoSphera at Radio Lac!

NOVEMBER 4, 2021

Gregory Segala was interviewed (interview in French) at Radio Lac to speak about biotech entrepreneurship, and the solution proposed by FluoSphera to make drug discovery more efficient and more respectful!

FluoSphera won the first stage of Venture Kick!

NOVEMBER 2, 2021

First-round validation! Venture Kick is now supporting FluoSphera with a grant of CHF 10’000 to start going to the market! 

FluoSphera will be present at the BIO-Europe Fall 2021!

OCTOBER 20, 2021

FluoSphera will be attending the BIO-Europe Fall 2021! Please come to visit our booth at the Swiss Biotech Pavillon!

FluoSphera obtained a grant from Fongit Innovation fund!

AUGUST 8, 2021

FluoSphera is grateful to receive CHF 50’000 from the Fongit Innovation Fund (FIF) for the acquisition of our service equipment! Big step forward before reaching the market!

Dr. Marie Shamseddin is the new CTO of FluoSphera!

AUGUST 1, 2021

FluoSphera is delighted to welcome Dr. Marie Shamseddin as the new Chief Technology Officer. Marie performed a career of life scientist in world-renowned Institutes. After a Ph.D. in Molecular Life Sciences at the EPFL, she did a post-doctoral training at the Wellcome Sanger Institute and at the Cambridge Institute for Medical Research. Thanks to her expertise, Marie will bring the technology of FluoSphera to the next level! 

FluoSphera got an Innogap grant!

JUNE 30, 2021

Unitec Technology Transfer Office will support FluoSphera with an Innogap grant of CHF 30’000 for the development of a new product to predict the cardiotoxicity of compounds in the presence of hepatic metabolism! Very grateful for that!

FluoSphera obtained the Innosuisse Core Coaching!

MARCH 26, 2021

Innosuisse has accepted to give the Innosuisse Core Coaching to FluoSphera to reach a sustainable growth. Many thanks to Innosuisse for this great support and to our coach Pierre Comte for his invaluable advice!

FluoSphera hires a CHIEF TECHNOLOGY OFFICER! 

FEBRUARY 9, 2021

FluoSphera hires a Chief Technology Officer (CTO) to develop further the technology of multi-tissue test system (proof-of-concept, prototyping, large-scale validation) and to strengthen the leadership team.

FluoSphera, winner of the pitch competition organised during the Start-up Day 2021 of Toulouse White Biotechnologies!

FEBRUARY 3, 2021

Every year, Toulouse White Biotechnologies (TWB) organises a start-up day to gather biotech players involved in a sustainable economy with a positive impact on environment. FluoSphera won the pitch competition “Go for it” , a specific track for pre-seed stage start-ups. 

A virtual booth for FluoSphera at the Swiss Startup Accelerator Showcase 2020!

DECEMBER 3, 2020

FluoSphera and other Geneus innovators participated in the Swiss Startup Accelerator Showcase 2020, organized by Innopeaks and La Forge (EPFL Innovation Park) startup accelerators. In a 3D model of the Swiss Convention centre, a virtual booth was created for each of the 30 startups participating in the pitch competition.

FluoSphera was the Winner of the Environment track and Grand Finalist of the iGEM Startup Showcase 2020! 

NOVEMBER 20, 2020

After being selected among more than 100 iGEM startups, FluoSphera won the pitch competition in the Environment track against 4 other startups, and was selected in the Top 3 startups for the Grand Finale of the iGEM Startup Showcase 2020.

FluoSphera joins the Bench2biz program, one of the best Startup Training in Switzerland.

NOVEMBER 13, 2020

FluoSphera has been accepted in the Bench2biz Workshop 2020. Intense sessions of training with Business and Industry experts from November 23 to December 4, 2020.

FluoSphera selected for the semi-finals of the iGEM Startup Showcase 2020.

NOVEMBER 12, 2020

FluoSphera has been selected in the Top 5 of the Environment Track for the semi-finals of the iGEM Startup Showcase 2020. This event will be organized by iGEM EPIC on November 20, 2020 to highlight the top iGEM Biofounders and to win an interview with the Y Combinator.

A financial support from Innosuisse to FluoSphera for the Proof-of-Concept and the Prototyping of our future assays

OCTOBER 16, 2020

We are very grateful to Innosuisse, the Swiss Agency for Innovation for this substantial grant for 18 months. It will support the Proof-of-Concept studies at the Science Innovation Hub in collaboration with ACCESS Geneva, and the design of several prototypes to deliver our first products by 2022.

FluoSphera benefits now from Innosuisse Initial Coaching

AUGUST 6, 2020

Innosuisse generously provides FluoSphera with a Startup Coaching with Pierre Comte, accredited Innosuisse Coach and Founder of Sigma Professional.

FluoSphera: Recipient of Two Awards from Science2market

JUNE 9, 2020

After 3 months within the Innosuisse Business Concept program, FluoSphera belongs to the Winning Projects and also won the Pitch Competition in the Life Sciences category.    

Gregory Segala, CEO of FluoSphera, invited at the Medical Research Center of Geneva (CMU) to give a seminar on the 3Rs

FEBRUARY 26, 2020

Gregory Segala will present the last alternative methods to animal experimentation. He will also take the opportunity to speak about the potential of FluoSphera to reduce animal experimentation.

FluoSphera joins Geneus!

DECEMBER 1, 2019

FluoSphera will be coached by Geneus’ innovation experts to learn how to efficiently convert an idea into an innovation.

FluoSphera won the Prize of the Best Idea in Life Sciences for the GEW Geneva 2019

NOVEMBER 22, 2019

During the Global Entrepreneurship Week (GEW) organized in Geneva, FluoSphera was selected as the Best Idea in Life Sciences by a jury of business and industry experts as well as experienced entrepreneurs.

FluoSphera won the Prize Innosciences to join the Science Innovation Hub!

NOVEMBER 8, 2019

For the inauguration of the Science Innovation Hub, FluoSphera was the recipient of the Prize Innosciences and will be hosted at the Faculty of Sciences of the University of Geneva (also hosting two Nobel Prize winners the same year!).

iGEM Geneva 2019 won a Silver Medal for the project FluoSphera at the iGEM Giant Jamboree in Boston

NOVEMBER 6, 2019

For the first participation of the University of Geneva in the iGEM (international Genetically Engineered Machine), the worldwide competition in synthetic biology, we won the Silver Medal for our project FluoSphera.

Release of the website on the project FluoSphera from iGEM Geneva 2019

OCTOBER 22, 2019

The website of the team iGEM Geneva 2019 presenting the method FluoSphera for the iGEM competition is now online.

Gregory Segala, First-Prize Winner of the I-Teams for the Development of the Encapsulation Technology

JANUARY 23, 2019

Gregory Segala, together with David Pejoski and Ozren Stojanovic, won the First-Prize of the I-Teams for the development of the encapsulation technology of FluoSphera.